Literature DB >> 12920052

Characterization of interleukin-4-stimulated nasal polyp fibroblasts.

John W Steinke1, Charles D Crouse, Dewayne Bradley, Kathleen Hise, Kevin Lynch, Stilianos E Kountakis, Larry Borish.   

Abstract

Chronic hyperplastic eosinophilic sinusitis is an inflammatory disease that results in the accumulation of eosinophils, fibroblasts, mast cells, and goblet cells at the site of injury. A common feature of this disease is the presence of nasal polyposis (NP). The current studies were designed to assess the contribution of interleukin (IL)-4 to fibroblast-mediated inflammation in chronic hyperplastic eosinophilic sinusitis/NP. In addition, we hypothesized that cysteinyl leukotrienes (CysLT) may directly influence fibroblast-mediated fibrotic and remodeling pathways in this disorder. Fibroblasts were isolated from NP tissue. All fibroblast lines expressed the IL-4 receptor. IL-4 induced changes in mRNA and protein expression of fibrotic (transforming growth factor-beta1 and -beta2) and inflammatory cytokines and chemokines (IL-6 and CCL11) by fibroblasts as measured by semiquantitative and quantitative polymerase chain reaction, RNase protection assay, and enzyme-linked immunosorbent assay. The expression of CysLT and other proinflammatory lipid receptors on fibroblasts was evaluated. CysLT1 and CysLT2 receptors were not expressed on fibroblasts; however, LPA(1) receptor was constitutively expressed and LPA(2) receptor expression was upregulated by IL-4. The metabolic cascade involved in CysLT synthesis was not expressed in fibroblasts and could not be induced by IL-4 treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920052     DOI: 10.1165/rcmb.2003-0071OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

Review 1.  The Role of the Fibroblast in Inflammatory Upper Airway Conditions.

Authors:  Stephen L Ball; Derek A Mann; Janet A Wilson; Andrew J Fisher
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

2.  Leukotriene Inhibitors in Sinusitis.

Authors:  John W Steinke; Joshua L Kennedy
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

3.  Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells.

Authors:  S Brandon Early; Elizabeth Barekzi; Julie Negri; Kathleen Hise; Larry Borish; John W Steinke
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

4.  Biological effects of leukotriene E4 on eosinophils.

Authors:  John W Steinke; Julie Negri; Spencer C Payne; Larry Borish
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-03-26       Impact factor: 4.006

5.  Sino-nasal outcome test (SNOT-22): a predictor of postsurgical improvement in patients with chronic sinusitis.

Authors:  Joshua L Kennedy; Matthew A Hubbard; Phillip Huyett; James T Patrie; Larry Borish; Spencer C Payne
Journal:  Ann Allergy Asthma Immunol       Date:  2013-07-30       Impact factor: 6.347

Review 6.  Leukotriene synthesis inhibitors versus antagonists: the pros and cons.

Authors:  John W Steinke; Jeffrey A Culp
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

7.  Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma.

Authors:  Kavita Pal; Xin Feng; John W Steinke; Marie D Burdick; Yun M Shim; Sun-Sang Sung; W Gerald Teague; Larry Borish
Journal:  Am J Respir Cell Mol Biol       Date:  2019-04       Impact factor: 6.914

8.  Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.

Authors:  Katherine N Cahill; Benjamin A Raby; Xiaobo Zhou; Feng Guo; Derek Thibault; Andreas Baccarelli; Hyang-Min Byun; Neil Bhattacharyya; John W Steinke; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

9.  Differential interleukin-10 production stratified by -571 promoter polymorphism in purified human immune cells.

Authors:  John W Steinke; Elizabeth Barekzi; Phillip Huyett; Larry Borish
Journal:  Cell Immunol       Date:  2008-01-11       Impact factor: 4.868

10.  Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Authors:  S B Early; P Huyett; K Brown-Steinke; L Borish; J W Steinke
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.